Despite the advances in immunotherapy, many cancer patients still do not respond to existing options.

Larkspur’s approach targets the unique ways that tumors hijack the immune system. We’re developing precision immunotherapies for molecularly-defined patient populations to overcome these bottlenecks that allow the tumor to subvert the immune system.

 

LEARN MORE ABOUT OUR SCIENCE